Aptevo Therapeutics Inc. - Common Stock (APVO)
1.5000
+0.00 (0.00%)
NASDAQ · Last Trade: Sep 17th, 7:52 AM EDT
The company stated that the 100% remission rate achieved at the highest dose level of the trial demonstrated the drug’s potential to redefine the frontline treatment landscape for newly diagnosed AML patients who are unfit for intensive chemotherapy.
Via Stocktwits · September 16, 2025
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Via Chartmill · September 16, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · September 16, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via Benzinga · June 21, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · June 20, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via Chartmill · June 20, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 20, 2025
Via Benzinga · June 20, 2025
Via Benzinga · June 20, 2025
Via Benzinga · June 20, 2025
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · June 19, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · June 18, 2025
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!
Via Chartmill · June 18, 2025
Via Benzinga · June 18, 2025
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · June 18, 2025
Aptevo stock spikes as new AML trial data show 85% remission rate with mipletamig triplet therapy, supported by strong safety and no CRS observed.
Via Benzinga · June 18, 2025
Via Benzinga · June 18, 2025
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · May 22, 2025
Via Benzinga · May 21, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via Chartmill · May 5, 2025